DALLAS, July 10, 2012 /PRNewswire/ -- ReportsnReports.com adds a new market research report "Global Markets for Stem Cells" to its store. The highlights of this stem cells report includes:
The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2016; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the stem cell-related drug market. The wider economic environment is also taken into account.
The report examines strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market.
SCOPE OF REPORT
This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.
MARKET ANALYSES AND FORECASTS
Market figures are based on revenues at the manufacturer level and are projected at 2012-dollar value without attempting to predict the effect of inflation/deflation. Therapeutic categories quantified and forecast include cancer, CNS diseases, infections and cardiovascular. Major country markets in three regionsAmericas, Europe and Asiaare analyzed and forecast, with a summary for the rest of the world.
METHODOLOGY
View original post here:
Global Markets for Stem Cells and Stem Cell Products Expected to Reach $6.6 Billion by 2016